|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 27489 |
FusionGeneSummary for PLCB2_JUP |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PLCB2_JUP | Fusion gene ID: 27489 | Hgene | Tgene | Gene symbol | PLCB2 | JUP | Gene ID | 5330 | 3728 |
| Gene name | phospholipase C beta 2 | junction plakoglobin | |
| Synonyms | PLC-beta-2 | CTNNG|DP3|DPIII|PDGB|PKGB | |
| Cytomap | 15q15.1 | 17q21.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2phosphoinositide phospholipase C-beta-2 | junction plakoglobincatenin (cadherin-associated protein), gamma 80kDadesmoplakin IIIdesmoplakin-3 | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q00722 | P14923 | |
| Ensembl transtripts involved in fusion gene | ENST00000260402, ENST00000557821, ENST00000456256, ENST00000543785, | ENST00000540235, ENST00000393930, ENST00000393931, ENST00000310706, | |
| Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 21 X 22 X 8=3696 |
| # samples | 3 | 29 | |
| ** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(29/3696*10)=-3.67183995140112 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: PLCB2 [Title/Abstract] AND JUP [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | JUP | GO:0002159 | desmosome assembly | 22889254 |
| Tgene | JUP | GO:0042127 | regulation of cell proliferation | 17924338 |
| Tgene | JUP | GO:0042307 | positive regulation of protein import into nucleus | 10825188|14661054 |
| Tgene | JUP | GO:0050982 | detection of mechanical stimulus | 18937352 |
| Tgene | JUP | GO:0051091 | positive regulation of DNA binding transcription factor activity | 14661054 |
| Tgene | JUP | GO:0071681 | cellular response to indole-3-methanol | 10868478 |
| Tgene | JUP | GO:0098609 | cell-cell adhesion | 18937352 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BF893068 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000260402 | ENST00000540235 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000260402 | ENST00000393930 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000260402 | ENST00000393931 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000260402 | ENST00000310706 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000557821 | ENST00000540235 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000557821 | ENST00000393930 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000557821 | ENST00000393931 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000557821 | ENST00000310706 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000456256 | ENST00000540235 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000456256 | ENST00000393930 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000456256 | ENST00000393931 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000456256 | ENST00000310706 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000543785 | ENST00000540235 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000543785 | ENST00000393930 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000543785 | ENST00000393931 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
| intron-intron | ENST00000543785 | ENST00000310706 | PLCB2 | chr15 | 40584336 | - | JUP | chr17 | 39919485 | - |
Top |
FusionProtFeatures for PLCB2_JUP |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PLCB2 | JUP |
| The production of the second messenger moleculesdiacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) ismediated by activated phosphatidylinositol-specific phospholipaseC enzymes. {ECO:0000269|PubMed:1644792}. | Common junctional plaque protein. The membrane-associated plaques are architectural elements in an importantstrategic position to influence the arrangement and function ofboth the cytoskeleton and the cells within the tissue. Thepresence of plakoglobin in both the desmosomes and in theintermediate junctions suggests that it plays a central role inthe structure and function of submembranous plaques. Acts as asubstrate for VE-PTP and is required by it to stimulate VE-cadherin function in endothelial cells. Can replace beta-cateninin E-cadherin/catenin adhesion complexes which are proposed tocouple cadherins to the actin cytoskeleton (By similarity).{ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PLCB2_JUP |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PLCB2_JUP |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PLCB2_JUP |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | JUP | P14923 | DB01593 | Zinc | Junction plakoglobin | small molecule | approved|investigational |
Top |
RelatedDiseases for PLCB2_JUP |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | JUP | C0023895 | Liver diseases | 1 | CTD_human |
| Tgene | JUP | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Tgene | JUP | C0232347 | No-Reflow Phenomenon | 1 | CTD_human |
| Tgene | JUP | C1969081 | Arrhythmogenic Right Ventricular Dysplasia, Familial, 12 | 1 | CTD_human;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|